Abbott Laboratories announced Lingo, its first over-the-counter continuous glucose monitor, is available in the U.S.

Abb0tt (NYSE:ABT) announced today that it made its Lingo continuous glucose monitoring system available without a ...

We're often told to eat a balanced diet full of fruit and vegetables, but some people opt out and eliminate almost all ...

Insulin resistance is associated with 31 different diseases and, in women, is also linked to higher odds of an early death, a ...

Abbott has officially launched its Lingo biowearable in the US, bringing its glucose coaching service to a huge new market.

Priced at $49 for one 14-day sensor, or $89 per month, Abbott’s offering is competitive with Dexcom’s Stelo sensor.

Fried foods, such as French fries, fried chicken, and doughnuts, are typically high in unhealthy trans fats and saturated ...

New over-the-counter sensors, an Abbott-Medtronic partnership and Roche’s first CGM are among diabetes technology’s top stories so far in 2024. Check out MedTech Dive’s roundup of the latest news.

A recent study reveals that intensive diabetes treatment can improve periodontal disease inflammation. Researchers found that two weeks of intensive diabetes treatment under hospitalization for ...

Pure Encapsulations Nitric Oxide Ultra is #3 on our list of the best nitric oxide booster supplements for men's wellness.

Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with ...

ABT made its CGM system Lingo available in the United States. The system can be used by consumers aged 18 years and older who ...